Establishment Labs (NASDAQ: ESTA) — Company Overview, News & Financial Data
Establishment Labs designs innovative breast implants with a focus on safety and aesthetics in aesthetic surgery.
Establishment Labs
Establishment Labs (NASDAQ:ESTA) specializes in designing, developing, and marketing innovative products for aesthetic surgery, focusing primarily on breast implants and related surgical goods. With a strong commitment to safety and aesthetics, its flagship product line, Motiva Implants®, stands out for its cutting-edge technology aimed at enhancing patient outcomes and satisfaction. Establishment Labs is committed to pushing the boundaries of medical aesthetics by investing in research and development to expand its product offerings and exploring new applications within the aesthetic and reconstructive sector. The company's mission revolves around improving patient safety and delivering exceptional aesthetic results, aiming to set new standards in the field.
Snapshot
Operations
Products and/or services of Establishment Labs
- MOTIVA® Breast Implants - Innovative breast implants with safety and aesthetic features, including Q Inside Safety Technology for device traceability.
- MOTIVA Flora® Tissue Expander - A device designed for breast reconstruction and augmentation, enabling tissue expansion before permanent implant placement.
- MOTIVA Ergonomix® - Dynamic breast implants that mimic natural breast tissue movement, providing a more natural look and feel.
- MOTIVA Minimally Invasive Mastectomy - A technique using MOTIVA implants for less invasive breast cancer treatment and reconstruction.
- Puregraft® - A system for autologous fat grafting, optimizing fat transfer procedures for aesthetic body contouring.
- MOTIVA Imagine® - A 3D imaging system helping patients visualize potential outcomes of breast augmentation or reconstruction using MOTIVA implants.
Establishment Labs executive team
- Fillipo Peter CaldiniCEO & Director
- S. Ross MansbachGeneral Counsel, Chief Compliance Officer & Chief Human Resources Officer
- Cassandra E. HarrisSenior VP & CFO
- Roberto de MezervilleChief Technology Officer
- Malavika WilliamVP, Global Head of Marketing & Communications
- Ivan BilicSenior Vice President of Commercial Operations - OUS
- Jeff EhrhardtSenior VP & GM of North America
Latest news about Establishment Labs
Key financials
Reported results for Establishment Labs, in USD.
- Market cap
- 2B
- Revenue (TTM)
- 245.8M
- P/E ratio
- —
- EPS (diluted, TTM)
- -1.3
- Dividend yield
- —
- Profit margin
- -15.8%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 211.1M | -39M | -51.1M | |
| 166M | -50M | -84.6M | |
| 165.2M | -65M | -78.5M | |
| 161.7M | -39.7M | -75.2M |